TITLE

High serum ferritin correlates with hepatic iron and predicts non-response to HCV therapy

AUTHOR(S)
Fehmi, Syed; Membreno, Fernando; Doshi, Hemang; Sifuentes, Darlene; Lau, Daryl T -Y
PUB. DATE
September 2003
SOURCE
American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS100
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
An abstract of the article "High Serum Ferritin Correlates With Hepatic Iron and Predicts Non-response to HCV Therapy," by Syed Fehmi, Fernando Membreno, Hemang Doshi, Darlene Sifuentes, and Daryl T.-Y. Lau is presented.
ACCESSION #
66954287

 

Related Articles

  • Znacaj uklanjanja gvo�da u terapiji hronicnog hepatitisa C. Nozic, Darko; Balint, Bela; Stankovic, Neboj�a; Dimitrijevic, Jovan; Ne�kovic, Gorana // Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journ;Feb2005, Vol. 62 Issue 2, p161 

    Background. It has been established that many patients with chronic hepatitis C have elevated serum iron, feritin levels and iron deposites in the liver. Therefore, the liver damage due to hepatitis C virus may be aggravated with iron overload. In many studies higher levels of iron in the blood...

  • Serum Iron Parameters as Predictors of Insulin Resistance in Non-Diabetic HCV +ve Patients on Chronic Hemodialysis. Mostafa Kamel, M. A. // Nature & Science;Aug2013, Vol. 11 Issue 8, p66 

    Background: Hepatitis C virus (HCV) infection is a common problem affecting more than 3% of the world population. The problem is more pronounced in hemodialysis centers. Insulin resistance is frequently seen in patients with HCV infection. Numerous studies indicated a link of insulin resistance...

  • Factors Predicting Interferon Treatment Response in Patients With Chronic Hepatitis C: Late Viral Clearance Does Not Preclude a Sustained Response. Ebeling, Freja; Lappalainen, Maija; Vuoristo, Matti; Nuutinen, Hannu; Leino, Rauli; Karvonen, Anna-Liisa; Lehtola, Juhani; Julkunen, Risto; Pohjanpelto, Pirkko; Färkkilä, Martti // American Journal of Gastroenterology;Apr2001, Vol. 96 Issue 4, p1237 

    OBJECTIVES: Because of the suboptimal efficacy, cost, and adverse effects of interferon in chronic hepatitis C (HCV). predictors have been sought to detect patients with a good treatment response. Also, markers for determining a poor response early in the course of therapy, such as the lack of...

  • Diabetes Is the Main Factor Accounting for the High Ferritin Levels Detected in Chronic Hepatitis C Virus Infection. Lecube, Albert; Hernández, Cristina; Genescà, Joan; Esteban, Joan I.; Jardí, Rosend; García, Lydia; Simó, Rafael // Diabetes Care;Nov2004, Vol. 27 Issue 11, p2669 

    OBJECTIVE -- A high prevalence of diabetes has been reported in patients with hepatitis C virus (HCV) infection. Both diabetes and HCV infection are associated with high serum ferritin levels. Although HCV infection could be the main factor responsible for the high ferritin levels, it is also...

  • Alanine aminotransferase flare-up in hepatitis C virus carriers with persistently normal alanine aminotransferase levels in a hyperendemic area of Japan. Uto, Hirofumi; Kurogi, Joji; Takahama, Yuka; Kusumoto, Kazunori; Hayashi, Katsuhiro; Ido, Akio; Kohara, Michinori; Stuver, Sherri O.; Moriuchi, Akihiro; Hasegawa, Susumu; Oketani, Makoto; Tsubouchi, Hirohito // Journal of Gastroenterology;Aug2007, Vol. 42 Issue 8, p673 

    The clinical features of hepatitis C virus (HCV) carriers with persistently normal alanine aminotransferase (PNALT) levels (ALT ≤ 34 IU/l) have not been fully elucidated. We investigated clinical factors associated with ALT flare-up in PNALT individuals in a HCV hyperendemic area of Japan....

  • Chronic Hepatitis C in the United States. Deresinki, Stan // Clinical Infectious Diseases;10/15/2006, Vol. 43 Issue 8, pvi 

    The article presents the abstract of the paper "The Prevalence of Hepatitis C virus infection in the United States, 1999 Through 2002," by G.L. Armstrong and colleagues.

  • CORRECTION.  // Annals of Internal Medicine;9/6/2005, Vol. 143 Issue 5, p395 

    Presents a correction to an article on patient-to-patient transmission of hepatitis C virus, published previously in the periodical "Annals of Internal Medicine."

  • Hematologic Disorders Associated with Hepatitis C Virus Infection and Their Management. Dieterich, Douglas T.; Spivak, Jerry L. // Clinical Infectious Diseases;8/15/2003, Vol. 37 Issue 4, p533 

    More than 4 million people in the United States are infected with hepatitis C virus (HCV). During the next 20-30 years, the burden of HCV-related mortality and morbidity will likely double. To date, the most effective treatment for chronic HCV infection is the combination of either interferon...

  • Hepatitis C Virus Infection: Immune Responsiveness and Interferon-a Treatment. Jirillo, E.; Pellegrino, N.M.; Piazzolla, G.; Caccavo, D.; Antonaci, S. // Current Pharmaceutical Design;Jan2000, Vol. 6 Issue 2, p169 

    Hepatitis C virus (HCV) is responsible for most cases of posttransfusion hepatitis and sporadic or community-acquired non-A, non-B hepatitis. Different generations of enzyme-linked immunosorbent assay have been generated for detecting antibodies to HCV epitopes. HCV-RNA quantitative analysis has...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics